Navigation Links
VacChina 2010 - A Premium Event to Define the Vaccine Industry in Asia
Date:6/25/2010

SHANGHAI, June 25 /PRNewswire-Asia/ --

"Life or death for a young child too often depends on whether he is born in a country where the vaccines are available or not."

-- Nelson Mandela

Hosted by Global Leaders Institute, world vaccine industry leaders will convene at VacChina 2010 on Sept 15 and 16 in Shanghai. The two-day executive summit will explore the major partnering opportunities in the vaccine industry in China. The goal of the summit is to bridge the China vaccine industry with the world in terms of vaccine R&D and production innovation and address needs of the entire industry to improve vaccine quality and safety.

At the end of 2009, the vaccine industry raised so much concern worldwide that the headlines of the business media were occupied by various kinds of news about vaccine enterprises. For example, Sinovac Biotech Co., Ltd. successfully landed the Nasdaq, then Simcere, a pharmaceutical company based in Jiangsu Province and listed on the NYSE, announced a 50.8% stake in Ealong Biotech and took control of the latter, and finally Novartis, the world-famous pharmaceutical company headquartered in Switzerland, acquired an 85.0% equity in Tianyuan Bio-Pharmaceutical, a vaccine producer, for RMB850M. These deals indicate that the investors and foreign pharmaceutical giants have not slowed down their pace to enter China's vaccine market, even in the face of this economic recession.

Over 150 attendees from vaccine producers home and abroad will gather under the same roof to elaborate on themes on the evolution of China's vaccine market and make comparisons to other emerging markets. Other topics will include the role of vaccines in the overall healthcare reform efforts in China and associated pricing strategies, future prospects of foreign vaccine products into China's EPI, China's intellectual property landscape, vaccine manufacturing in China, quality and safety from design to operations, bridging the gap between R&D and production, low cost novel purification platforms for vaccine production capacity and quality etc.

Renowned presenters speaking at the main conference on Sept 15 and 16 include Weidong Yin from Sinovac China, Xiaohang Ding from Zhejiang Tianyuan Bio-Pharmaceutical, Bing Zeng from Sinopharm, Xiaohan Du from Simcere Pharmaceutical Group, Pierre Trotemann from Sanofi Pasteur, Shou-Bai Chao from MedImmune, etc.

    For more information, please contact:

     Daniel Chen
     Tel:   +86-21-3251-6046

    Or visit the website http://www.globaleaders.com/en/2010/vac/index.asp


'/>"/>
SOURCE Global Leaders Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Myelin Removal Beads: Premium Efficiency for Neural Cell Separations and Antibody Stainings
2. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
3. Replidynes Investigational Antibacterial Agent REP3123 Prevents Sporulation in Clostridium difficile
4. Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile
5. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
6. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
7. U.S. Preventive Medicine Acquires Specialty Disease Management
8. For Most, Good Oral Care Does More Than Antibiotics to Prevent Dental-Related Heart Problems, Reports the Harvard Heart Letter
9. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
10. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
11. Inhaled Steriods Used as Preventive Treatment Post 9/11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... , Sept. 6, 2017  Medical professionals ... and skills while treating their patients. Medical ... experience without involving patients. Simulation provides a ... can carry out procedures, refine techniques and ... Integration of new technology, such as augmented ...
(Date:9/5/2017)... Colo. , Sept. 5, 2017 Sapheneia ... XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party Vendor ... existing CT scanners and allows compliance with current MITA ... Sapheneia-Scannerside proprietary XR 29 DoseCheck solution is specifically designed ... and alerts of potential radiation doses over a predefined ...
(Date:9/5/2017)... Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ORMP) ... the development of oral drug delivery systems, announced today ... U.S. Food and Drug Administration (FDA) regarding ORMD-0801, the ... At the meeting, the FDA gave clear ... would be a Biologics License Application (BLA).  Such a ...
Breaking Medicine Technology:
(Date:9/26/2017)... ... September 26, 2017 , ... Atmosera ... Release Management as a Service (RMaaS) to automate the deployment of ... include any companies, e-tailers, and web development agencies who want to improve time-to-revenue ...
(Date:9/26/2017)... ... September 26, 2017 , ... Two ... only entirely new and different, it is scientifically proven as well: ABAlife™. Euromed ... has received an exclusive license agreement with BioTherapeutics Inc. for patented technology for ...
(Date:9/26/2017)... ... 26, 2017 , ... After a summer-long contest to crown ... Designated Drivers proudly announced the winners of the HEROtini Mocktail Challenge at the ... on the challenge of competing in three categories: Best HEROtini Mocktail, Top HEROtini ...
(Date:9/26/2017)... Falls Church, VA (PRWEB) , ... September 26, 2017 , ... ... FDAnews and Cerulean Associates LLC **, Dec. 5-6, 2017 – Arlington, VA, http://www.fdanews.com/fdadataintegrity ... its investigators: “If initial findings indicate the firm’s electronic records may not be trustworthy ...
(Date:9/26/2017)... Scotch Plains, NJ (PRWEB) , ... September 26, ... ... Surgery Fellowship trained orthopedic surgeon and the Chair of the Leg, Ankle, and ... Dr. Kovatis is currently the only fellowship trained orthopedic surgeon at Hackensack UMC ...
Breaking Medicine News(10 mins):